Skip to main content

Plewman Patrick's Form 4 filing

Quest Diagnostics Inc (DGX) · filed Feb 12, 2026

Accession no.
0001022079-26-000008
Filed
Feb 12, 2026
Trade date
Jan 28-Feb 10, 2026
Filing delay
15 daysLate
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.16M. It was filed 15 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Plewman PatrickCIK 0001497368Officer (SVP for Diagnostic Services)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 28, 2026Common StockAGrant or awardAcquired+48$183.51+$8,808.4815,381Direct
Feb 10, 2026Common StockMOption exerciseAcquired+5,662$121.81+$689,688.2221,043Direct
Feb 10, 2026Common StockSSaleDisposed−5,662$204.00−$1,155,04815,381Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 10, 2026Common StockMOption exerciseDisposed−5,662$121.81−$689,688.220Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)